- Home
- GOSS vs SMTI Comparison
GOSS vs SMTI Comparison
Compare GOSS & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOSS
- SMTI
- Stock Information
- Founded
- GOSS 2015
- SMTI 1982
- Country
- GOSS United States
- SMTI United States
- Employees
- GOSS 135
- SMTI N/A
- Industry
- GOSS Biotechnology: Pharmaceutical Preparations
- SMTI Medical/Dental Instruments
- Sector
- GOSS Health Care
- SMTI Health Care
- Exchange
- GOSS Nasdaq
- SMTI Nasdaq
- Market Cap
- GOSS 214.7M
- SMTI 256.9M
- IPO Year
- GOSS 2019
- SMTI N/A
- Fundamental
- Price
- GOSS $0.97
- SMTI $32.95
- Analyst Decision
- GOSS Strong Buy
- SMTI Buy
- Analyst Count
- GOSS 5
- SMTI 1
- Target Price
- GOSS $9.20
- SMTI $44.00
- AVG Volume (30 Days)
- GOSS 942.3K
- SMTI 28.8K
- Earning Date
- GOSS 11-07-2024
- SMTI 11-11-2024
- Dividend Yield
- GOSS N/A
- SMTI N/A
- EPS Growth
- GOSS N/A
- SMTI N/A
- EPS
- GOSS N/A
- SMTI N/A
- Revenue
- GOSS $95,842,000.00
- SMTI $72,410,222.00
- Revenue This Year
- GOSS N/A
- SMTI $26.97
- Revenue Next Year
- GOSS N/A
- SMTI $18.91
- P/E Ratio
- GOSS N/A
- SMTI N/A
- Revenue Growth
- GOSS N/A
- SMTI 21.42
- 52 Week Low
- GOSS $0.45
- SMTI $26.00
- 52 Week High
- GOSS $1.60
- SMTI $43.25
- Technical
- Relative Strength Index (RSI)
- GOSS 48.28
- SMTI 56.84
- Support Level
- GOSS $0.98
- SMTI $30.29
- Resistance Level
- GOSS $1.09
- SMTI $32.51
- Average True Range (ATR)
- GOSS 0.06
- SMTI 1.72
- MACD
- GOSS -0.01
- SMTI 0.31
- Stochastic Oscillator
- GOSS 21.83
- SMTI 100.00
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.